Abstract Cancer tumor classification based on morphological characteristics alone has been shown to have serious limitations. Breast, lung, colorectal, thyroid, and ovarian are the most commonly diagnosed cancers among women. Precise classification of cancers into their types is considered a vital problem for cancer diagnosis and therapy. In this paper, we proposed a stacking ensemble deep learning model based on one-dimensional convolutional neural network (1D-CNN) to perform a multi-class classification on the five common cancers among women based on RNASeq data. The RNASeq gene expression data was downloaded from Pan-Cancer Atlas using GDCquery function of the TCGAbiolinks package in the R software. We used least absolute shrinkage and s...
Background: Detecting breast cancer in its early stages remains a significant challenge in the prese...
Breast cancer is a serious disease and the leading cause of death in women. Breast cancer can be dia...
Breast cancer accounts for 30% of all female cancers. Accurately distinguishing dangerous malignant ...
Ensemble learning combines multiple learners to perform combinatorial learning, which has advantages...
Abstract Molecular level diagnostics based on microarray technologies can offer the methodology of p...
Cancer classification is a topic of major interest in medicine since it allows accurate and efficien...
Nowadays, The gene expression analysis gains a significant research interest and plays an important ...
Breast cancer (BC) is currently the most common form of cancer diagnosed worldwide with an incidence...
Publisher Copyright: © 2021 Elsevier LtdIn this work, the effectiveness of the deep learning model i...
With recent advances in DNA sequencing technologies, fast acquisition of large-scale genomic data ha...
Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most common forms of lung cancer. T...
Traditional screening of cervical cancer type classification majorly depends on the pathologist’s ex...
Breast cancer is one of the leading cancers among women. It has the second-highest mortality rate in...
The high death rate and overall complexity of the cancer epidemic is a global health crisis. Progres...
Cancer is one of the most prevalent diseases worldwide. The most prevalent condition in women when a...
Background: Detecting breast cancer in its early stages remains a significant challenge in the prese...
Breast cancer is a serious disease and the leading cause of death in women. Breast cancer can be dia...
Breast cancer accounts for 30% of all female cancers. Accurately distinguishing dangerous malignant ...
Ensemble learning combines multiple learners to perform combinatorial learning, which has advantages...
Abstract Molecular level diagnostics based on microarray technologies can offer the methodology of p...
Cancer classification is a topic of major interest in medicine since it allows accurate and efficien...
Nowadays, The gene expression analysis gains a significant research interest and plays an important ...
Breast cancer (BC) is currently the most common form of cancer diagnosed worldwide with an incidence...
Publisher Copyright: © 2021 Elsevier LtdIn this work, the effectiveness of the deep learning model i...
With recent advances in DNA sequencing technologies, fast acquisition of large-scale genomic data ha...
Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most common forms of lung cancer. T...
Traditional screening of cervical cancer type classification majorly depends on the pathologist’s ex...
Breast cancer is one of the leading cancers among women. It has the second-highest mortality rate in...
The high death rate and overall complexity of the cancer epidemic is a global health crisis. Progres...
Cancer is one of the most prevalent diseases worldwide. The most prevalent condition in women when a...
Background: Detecting breast cancer in its early stages remains a significant challenge in the prese...
Breast cancer is a serious disease and the leading cause of death in women. Breast cancer can be dia...
Breast cancer accounts for 30% of all female cancers. Accurately distinguishing dangerous malignant ...